Dr. Reddy's Receives FDA Tentative Approval for Zenavod Capsules, 40 mg for Treatment of Rosacea in Adults

By: via Benzinga
Dr. Reddy's Laboratories (NYSE: RDY), announced today the U.S. Food and Drug Administration (US FDA) tentative ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.